StonvexLoading…
StonvexStonvexStonvexCore line items from DKNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.65B | $6.05B | $4.07B | $2.92B |
Operating Income | $5.85M | $-15.82M | $-167.58M | $104.31M |
Net Income | $21.07M | $3.71M | $-132.72M | $157.94M |
EPS (Diluted) | $0.03 | $-0.01 | $-0.27 | $0.23 |
Total Assets | $4.31B | $4.53B | $4.62B | $4.47B |
Total Liabilities | $3.70B | $3.90B | $3.89B | $3.46B |
Cash & Equivalents | $999.40M | $1.13B | $1.23B | $1.26B |
Free Cash Flow OCF − CapEx | $-55.52M | $647.50M | $330.99M | $47.94M |
Shares Outstanding | 510.63M | 495.90M | 495.52M | 529.55M |